(Q44132900)

30 November 2017

0 references

On the anxiogenic and anxiolytic nature of long-term cerebral 5-HT depletion following MDMA. (English)

1 reference

30 November 2017

A Richard Green

1

1 reference

30 November 2017

Iain S McGregor

series ordinal

2

1 reference

30 November 2017

language of work or name

1 reference

1 August 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

162

1 reference

30 November 2017

issue

4

1 reference

30 November 2017

page(s)

448-450

1 reference

Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users

30 November 2017

cites work

1 reference

12 December 2020

A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters, and their response to diazepam

1 reference

12 December 2020

Mood state and brain electric activity in ecstasy users.

1 reference

12 December 2020

Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy").

1 reference

12 December 2020

Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.

1 reference

12 December 2020

Effects of 5,7-dihydroxytryptamine depletion of tissue serotonin levels on extracellular serotonin in the striatum assessed with in vivo microdialysis: relationship to behavior

1 reference

12 December 2020

Trial 2 in the elevated plus-maze: a different form of fear?

1 reference

12 December 2020

Effect of serotonergic lesion on "anxious" behaviour measured in the elevated plus-maze test in the rat.

1 reference

12 December 2020

Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion

1 reference

12 December 2020

Acute amino acid loads that deplete brain serotonin fail to alter behavior

1 reference

12 December 2020

Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity

1 reference

12 December 2020

Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research

1 reference

12 December 2020

1 reference

12 December 2020

5‐HT loss in rat brain following 3, 4‐methylenedioxymethamphetamine (MDMA), p‐chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine

1 reference

12 December 2020

A review of the validity and variability of the elevated plus-maze as an animal model of anxiety

1 reference

12 December 2020

A study of the effect of a single neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy") on the subsequent long-term behaviour of rats in the plus maze and open field

1 reference

12 December 2020

5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research

1 reference

12 December 2020

Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users.

1 reference

12 December 2020

Anxiogenic and depressive-like effects, but no cognitive deficits, after repeated moderate tryptophan depletion in the rat.

1 reference

12 December 2020

10.1007/S00213-002-1158-3

Identifiers

DOI

1 reference

30 November 2017

1 reference